Filing Flows › Exagen (XGN) › Capital expenditures
Exagen (XGN) capital expenditures by quarter
Exagen's capital expenditures were $543K in Q2 2026 (second quarter 2026), +97% from Q3 2025. Over the last 3 quarters it ranged from $146K (Q4 2024) to $543K (Q2 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $543K | +97% | — |
| Q3 2025 | $275K | +88% | — |
| Q4 2024 | $146K | — | — |
Q2 2026 at a glance
Exagen, Q2 2026: revenue $19.9M (+16% year over year), operating margin -8.6%, net loss $3.2M, operating cash flow $4.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Exagen's capital expenditures?
Exagen's capital expenditures were $543K in Q2 2026 (second quarter 2026), +97% from Q3 2025.
How has Exagen's capital expenditures changed?
Over the last 3 quarters it ranged from $146K (Q4 2024) to $543K (Q2 2026).